Scedosporium prolificans osteomyelitis following penetrating injury: A case report

Cortez, 2008, Infections caused by Scedosporium spp, Clin Microbiol Rev, 21, 157, 10.1128/CMR.00039-07 Garcia-Vidal, 2009, Fungal postoperative spondylodiscitis due to Scedosporium prolificans, Spine J, 9, e1, 10.1016/j.spinee.2009.03.012 Kesson, 2009, Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: a case report, Clin Infect Dis, 48, 1257, 10.1086/597772 Studahl, 2003, Bone and joint infection after traumatic implantation of Scedosporium prolificans treated with voriconazole and surgery, Acta Paediatr, 92, 980, 10.1111/j.1651-2227.2003.tb00636.x Steinbach, 2003, Scedosporium species infections and treatments, J Chemother, 15, 16, 10.1179/joc.2003.15.Supplement-2.16 Dalton, 2006, Scedosporium prolificans: an uncommon cause of septic arthritis, ANZ J Surg, 76, 661, 10.1111/j.1445-2197.2006.03796.x Steinbach, 2003, Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanide, J Clin Microbiol, 41, 3981, 10.1128/JCM.41.8.3981-3985.2003 Rodriguez-Tudela, 2009, Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases, Med Mycol, 47, 359, 10.1080/13693780802524506 Hopwood, 1995, Scedosporium prolificans, a multiresistant fungus, from a UK aids patient, J Infect, 30, 153, 10.1016/S0163-4453(95)80011-5 Gosbell, 1999, Clinical, pathologic and epidemiologic features of infection with Scedosporium prolificans: four cases and review, Clin Microbiol Infect, 5, 672, 10.1111/j.1469-0691.1999.tb00513.x Cuenca-Estrella, 1999, Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum, J Antimicrob Chemother, 43, 149, 10.1093/jac/43.1.149 Troke, 2008, Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients, Antimicrob Agents Chemother, 52, 1743, 10.1128/AAC.01388-07 Meletiadis, 2000, Combination chemotherapy for the treatment of invasive infections by Scedosporium prolificans, Clin Microbiol Infect, 6, 336, 10.1046/j.1469-0691.2000.00089.x Meletiadis, 2003, in vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedospotium prolificans isolates, Antimicrob Agents Chemother, 47, 106, 10.1128/AAC.47.1.106-117.2003 Meletiadis, 2002, in vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates, Antimicrob Agents Chemother, 46, 62, 10.1128/AAC.46.1.62-68.2002 Ruth Ashbee, 2013, Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology, J Antimicrob Chemother Posterard, 2013, MALDI-TOF mass spectrometry in the clinical mycology laboratory: identification of fungi and beyond, Expert Rev Proteomics, 10, 151, 10.1586/epr.13.8 Lau, 2013, Development of a clinically comprehensive database and a simple procedure for identification of molds from solid media by matrix-assisted laser desorption ionization-time of flight mass spectrometry, J Clin Microbiol, 51, 828, 10.1128/JCM.02852-12 Ritter, 2013, Exserohilum infections associated with contaminated steroid injections: a clinicopathologic review of 40 cases, Am J Pathol, 183, 881, 10.1016/j.ajpath.2013.05.007 Cetrulo, 2012, A multi-disciplinary approach to the management of fungal osteomyelitis: current concepts in post-traumatic lower extremity reconstruction: a case report, Microsurgery, 32, 144, 10.1002/micr.20956